Inactive Instrument
Intellego Technologies AB Stock
Stocks
INT
SE0016075063
Biotechnology & Medical Research
| 1 day | +4.96% |
| Manager | Title | Age | Since |
|---|---|---|---|
Simon Marshall
CEO | Chief Executive Officer | - | - |
Henrik Resmark
DFI | Director of Finance/CFO | 57 | 2026-02-09 |
Laila Ostertag
CTO | Chief Tech/Sci/R&D Officer | - | 2021-08-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Carl Olsson
CHM | Chairman | 64 | 2026-02-22 |
| Director/Board Member | 63 | 2026-02-22 | |
Mats Geijer
BRD | Director/Board Member | 49 | 2026-02-22 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/16/25 | Buy | Chief Executive Officer | 3,000 | 0.0101% | ||
| 9/15/25 | Buy | Chief Executive Officer | 2,805 | 0.0095% | ||
| 9/9/25 | Buy | Chief Executive Officer | 363 | 0.0012% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.96% | +13.54% | - | - | 167M | |
| -0.21% | -4.43% | +44.40% | +74.13% | 66.22B | |
| -2.36% | +1.37% | +8.43% | +70.55% | 55.2B | |
| +0.88% | +3.91% | +12.04% | +91.51% | 52.79B | |
| +3.28% | +5.58% | +26.51% | +50.05% | 45.53B | |
| +0.51% | +9.95% | +22.40% | +133.92% | 43.94B | |
| -1.15% | +0.39% | +263.21% | +594.60% | 41.64B | |
| +0.10% | +9.90% | +16.11% | +59.33% | 34B | |
| -8.38% | -6.95% | +26.35% | -1.93% | 25.84B | |
| +0.76% | +4.39% | +37.50% | +27.35% | 23.51B | |
| Average | -0.49% | +4.07% | +50.77% | +122.17% | 43.19B | |
| Weighted average by Cap. | -0.80% | +3.72% | +49.66% | +126.50% |
Employees
64
Calendar
